Kamada director awarded options at $5.99 and $7.38

The options vest in four equal annual installments, and their exercise prices were adjusted in connection with a special cash dividend.

Rhea-AI Filing Summary

KAMADA LTD's Form 4 for director David Tsur reports two employee stock-option awards held by a trustee under the company's 2011 Share Award Plan: options covering 7,500 ordinary shares at $5.99 and 30,000 ordinary shares at $7.38. Both exercise prices were adjusted in connection with a special cash dividend declared August 17, 2026, with an August 27, 2026 record date. The options vest over four years in four equal installments, with 25% vesting on each grant-date anniversary. The U.S.-dollar prices are convenience conversions from NIS using the Bank of Israel rate as of September 22, 2026.

Insider Trade Summary

Grant/Award: 37,500 shares

Grant/Award 2 txns

Insider Tsur David

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy) F1, F4, F2, F3	7,500	$0.00	$0.00
Grant/Award	Employee Stock Option (right to buy) F1, F5, F2, F3	30,000	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (right to buy) — 37,500 contracts (Indirect, Held by trustee)

Footnotes (5)

1. F1. The exercise price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 22, 2026.
2. F2. The options vested over a period of four years in four equal installments, such that 25% of the options vested on each anniversary of the grant date.
3. F3. Held by trustee under the Company's 2011 Share Award Plan.
4. F4. This option was previously reported as covering 7,500 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
5. F5. This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.55. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

Key Figures

Options covering ordinary shares: 7,500 shares Exercise price: $5.99 per share Options covering ordinary shares: 30,000 shares +5 more

8 metrics

Options covering ordinary shares 7,500 shares Award reported August 27, 2026; held by a trustee under the 2011 Share Award Plan.

Exercise price $5.99 per share For the option covering 7,500 ordinary shares; U.S.-dollar convenience conversion from NIS using the Bank of Israel rate as of September 22, 2026.

Options covering ordinary shares 30,000 shares Award reported August 27, 2026; held by a trustee under the 2011 Share Award Plan.

Exercise price $7.38 per share For the option covering 30,000 ordinary shares; U.S.-dollar convenience conversion from NIS using the Bank of Israel rate as of September 22, 2026.

Previously reported exercise price $6.15 per share Previously reported for the option covering 7,500 ordinary shares, before adjustment in connection with the special cash dividend.

Previously reported exercise price $7.55 per share Previously reported for the option covering 30,000 ordinary shares, before adjustment in connection with the special cash dividend.

Vesting period Four years Options vest in four equal installments, with 25% vesting on each grant-date anniversary.

Vesting installment 25% Vests on each anniversary of the grant date.

Key Terms

Employee Stock Option (right to buy), exercise price, 2011 Share Award Plan, special cash dividend distribution

4 terms

Employee Stock Option (right to buy) financial

"Employee Stock Option (right to buy)"

exercise price financial

"The exercise price has been adjusted"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

2011 Share Award Plan financial

"Held by trustee under the Company's 2011 Share Award Plan"

special cash dividend distribution financial

"adjusted in connection with a special cash dividend distribution"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What option awards were reported for KMDA director David Tsur?

The Form 4 reports employee stock options covering 7,500 ordinary shares and 30,000 ordinary shares, held by a trustee under KAMADA LTD's 2011 Share Award Plan. Both awards are dated August 27, 2026.

What are the exercise prices for the KMDA options?

The exercise prices are $5.99 for the option covering 7,500 ordinary shares and $7.38 for the option covering 30,000 ordinary shares. The U.S.-dollar amounts are convenience conversions from NIS using the Bank of Israel rate as of September 22, 2026.

How do the KMDA options vest?

The options vest over four years in four equal installments, with 25% vesting on each anniversary of the grant date.

Why were the KMDA option exercise prices adjusted?

The exercise prices were adjusted in connection with a special cash dividend declared by KAMADA LTD's board on August 17, 2026, with a record date of August 27, 2026. The options were previously reported at $6.15 and $7.55, respectively.

Were the KMDA transactions reported under a Rule 10b5-1 plan?

No Rule 10b5-1 plan is reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/23/2026 - 07:14 AM Accepted by SEC EDGAR 09/23/2026 - 07:14 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tsur David

(Last) (First) (Middle)

2 HOLTZMAN ST.

(Street)

REHOVOT

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$5.99(1)(4)	08/27/2026		A		7,500		(2)	(2)	Ordinary Shares	7,500	$0.00	7,500	I	Held by trustee(3)
Employee Stock Option (right to buy)	$7.38(1)(5)	08/27/2026		A		30,000		(2)	(2)	Ordinary Shares	30,000	$0.00	30,000	I	Held by trustee(3)

Explanation of Responses:

1. The exercise price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 22, 2026.

2. The options vested over a period of four years in four equal installments, such that 25% of the options vested on each anniversary of the grant date.

3. Held by trustee under the Company's 2011 Share Award Plan.

4. This option was previously reported as covering 7,500 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

5. This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.55. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

	/s/ David Tsur	09/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)